Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!
Abstract Background. Substantial evidence supports the use of adjuvant trastuzumab with chemotherapy for patients with human epidermal growth factor receptor (HER)-2+ breast cancer ; however, a lesser ...
BACKGROUND The Canadian health care system provides equitable access to equivalent standards of care . The authors investigated to determine whether patients with breast cancer who had different ...
patients and may have a significant impact on health care resources. We investigated the use and effectiveness of adjuvant trastuzumab in daily practice compared with the effectiveness in clinical trials ...
with metastatic breast cancer . Several trials have been initiated to evaluate the adjuvant use of trastuzumab in early-stage breast cancer . This issue of AJHP features a therapy update by Kabe and Kolesar ...
of the Cancer Care Ontario Neelima Denduluri, US Oncology Clinical Practice Guideline Network, Virginia Cancer Specialists, Arlington; Jamie N. Holloway, Patient Neelima Denduluri, Mark R. Somerfield, Andrea Eisen ...
Crossref Search ADS PubMed WorldCat 15 Groenvold M , Fayers PM, Petersen MA. et al. Breast cancer patients on adjuvant chemotherapy report a wide range of problems not identified by health ‐ care staff ...
for regional breast cancer patients at different stages of their care (diagnosis/treatment, remission, and pre-terminal and terminal for those dying from cancer ) were estimated using gamma regression. Following ...
in the treatment of HER2-positive, locally recurrent, unresectable or metastatic breast cancer , the use of pertuzumab in combination with trastuzumab and docetaxel gained FDA approval in that patient population.31 ...
study Clin Breast Cancer 2006 ; 7 : 153 – 157 Google Scholar Crossref Search ADS PubMed WorldCat 4 Pusztai L , Esteva FJ Continued use of trastuzumab (Herceptin) after progression on prior trastuzumab ...
-positive breast cancer . We investigated the cost-effectiveness of this regimen. Methods A Markov-based microsimulation model with six health states is used to simulate four adjuvant therapy options for women ...
Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!